Thermo Fisher Scientific (TMO) Tops Q3 EPS by 6c

Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $2.31, $0.06 better than the analyst estimate of $2.25. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $5.3 million.

GUIDANCE:

Thermo Fisher Scientific sees FY2017 EPS of $9.29-$9.38, versus the consensus of $9.35. Thermo Fisher Scientific sees FY2017 revenue of $20.50-2.66 billion, versus the consensus of $20.51 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c